After a strong 6 months that has seen the best growth spurt in its history, Lonza is raising its guidance for the rest of the year.
Germany’s hybrid CRO-biotech Evotec has had a better few months than expected as it announces stronger profits for 2016 ahead of its half-year results on Aug.…
CRO giant Parexel has seen its chief financial officer and senior vice president Ingo Bank resign from the company over the weekend, according to a SEC filing.
CRO giant Parexel has posted new growth figures showing it looks to grow by 10% to 12% each year, spurred by both ongoing ops and growth from recent buys.
San Diego- and China-based BioDuro, which merged with San Diego’s Formex late last year, announced at BIO this week its formal acquisition of Formex to form…
INC Research booked strong growth in the first quarter as rumors swirl that it may well be the next big purchase for LabCorp.
Icon saw steady growth of 3.1% for the first quarter as sales just tipped the $400 million mark.
With news reports suggesting Pfizerhas killed off its planned $160 billion megamerger with Allergan after a crackdown from the U.S. Treasury, CROs may have a…
PRA Health Sciences posted a solid set of financials for the fourth quarter as it predicts double-digit growth in the coming year.
Covance has helped buoy LabCorp earnings in the fourth quarter as its leadership team hails a "transformative year."